ESMO 2018
Interviews and expert commentary tagged “ESMO 2018” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer
MUNICH—More than four years median overall survival was reported in patients treated with an inhibitor of anaplastic lymphoma kinase (ALK) for their ALK gene rearranged non-small cell lung cancer (NSC
27 October 2018
7 minutes